4.6 Letter

Timing of Statistical Benefit of Mineralocorticoid Receptor Antagonists Among Patients With Heart Failure and Post-Myocardial Infarction

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Spironolactone for Heart Failure with Preserved Ejection Fraction

Bertram Pitt et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Medicine, General & Internal

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.

Faiez Zannad et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)